Synairgen rolls out home-based COVID-19 trial nationally
Respiratory drug developer Synairgen has announced the expansion of the placebo-controlled home setting clinical trial of SNG001 in patients with COVID-19 beyond the Southampton area...
Thu, 18/06/2020 - 09:54